COLET (NCT02322814): A multistage, phase 2 study evaluating the safety and efficacy of cobimetinib (C) in combination with paclitaxel (P) as first-line treatment for patients (pts) with metastatic triple-negative breast cancer (TNBC).
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS1100-TPS1100
◽
Keyword(s):
Phase 2
◽
Keyword(s):
Keyword(s):